Opt-out testing for hepatitis B and C infections in adults attending the Emergency Department of a large London Teaching Hospital

The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda

(2023) Emily Martyn et al.   eLife

Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis

(2022) JiHyun An et al.   Journal of Personalized Medicine

Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside

(2021) Don C. Rockey et al.   GASTROENTEROLOGY

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

(2021) Isabelle Andrieux-Meyer et al.   Lancet Gastroenterology & Hepatology

Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers

(2021) Niall C. Anderson et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma

(2018) George N. Ioannou et al.   JOURNAL OF HEPATOLOGY